Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson Wins Jury Verdict Over Levaquin Warning
Bloomberg
Friday, January 27, 2012 - 10:32am
tags:
JNJ, Levaquin, warnings
Pfizer Sued By Employees Over Retirement Plans
Pharmalot
Friday, January 27, 2012 - 10:31am
tags:
retirement, Pfizer
Apricus Biosciences expands offerings through agreement with PediatRx
The Fly on the Wall
Friday, January 27, 2012 - 10:26am
tags:
PediatRx, Apricus Biosciences, Granisol
Warner Chilcott expects 2012 revenue to fall on bone-drug volume declines in the US
Yahoo/AP
Friday, January 27, 2012 - 10:22am
tags:
Warner Chilcott, guidance
Has GlaxoSmithKline Become the Perfect Stock?
Motley Fool
Friday, January 27, 2012 - 10:20am
tags:
GSK
Spectrum Pharma: Solid Tech, Solid Fundamentals, Explosive Growth
Seeking Alpha
Friday, January 27, 2012 - 10:19am
tags:
Spectrum Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, Teva Pharmaceuticals
[video] Cramer: Biogen Idec's Profit Pipeline
CNBC
Friday, January 27, 2012 - 10:17am
tags:
Biogen Idec, multiple sclerosis
Merrimack IPO: Repackaging And Refining Chemotherapy
Seeking Alpha
Friday, January 27, 2012 - 10:15am
tags:
IPOs, Merrimack Pharmaceuticals, chemotherapy
Past Bouncers And Others Biotech Plays Ready To Move
Seeking Alpha
Thursday, January 26, 2012 - 2:15pm
tags:
Aeterna Zentaris, Affymax, Ampio, Bacterin International Holdings, GelTech, Cel-Sci, Ista, Inovio, Lpath, Nabi, Novavax, PharmAthene
Illumina adopts poison pill to stave off Roche
Reuters
Thursday, January 26, 2012 - 2:12pm
tags:
Illumina, Roche, poison pill, M&A, hostile bid
Does This Interesting Development Regarding Pharmacyclics Mean we should buy?
Motley Fool
Thursday, January 26, 2012 - 2:11pm
tags:
Pharmacyclics
Amgen Agrees to Purchase Micromet for $1.16 Billion to Gain Leukemia Drug
Bloomberg
Thursday, January 26, 2012 - 1:09pm
tags:
Amgen, M&A, Micromet, leukemia
Celgene To The FDA: Oh… That White Paper
Pharmalot
Thursday, January 26, 2012 - 1:08pm
tags:
FDA, white paper, Celgene, Abraxane, Abraxis BioScience
Momenta tumbles on Lovenox court ruling
Marketwatch
Thursday, January 26, 2012 - 12:47pm
tags:
Momenta, Lovenox, Amphastar, Watson Pharmaceuticals, Sanofi
Forbes Earnings Preview: Pfizer
Forbes
Thursday, January 26, 2012 - 12:45pm
tags:
Pfizer, earnings
Celgene Buying Small Biotech Avila
Investors.com
Thursday, January 26, 2012 - 11:32am
tags:
M&A, Celgene, Avila
Watson Confirms Court Stays Preliminary Injunction Permits Launch of Generic Lovenox
Marketwatch
Thursday, January 26, 2012 - 11:31am
tags:
Watson Pharmaceuticals, Sanofi, Lovenox, generics, Amphastar
Sanofi Starts Late-Stage Trial of Eliglustat for Gaucher Disease
Bloomberg
Thursday, January 26, 2012 - 11:28am
tags:
eliglustat tartrate, Gaucher disease, Sanofi
Roche’s Illumina Bid May Spur Buying in DNA Test Land Grab
Bloomberg
Thursday, January 26, 2012 - 11:27am
tags:
Roche, Illumina, hostile bid, DNA scanning, Life Technologies, Affymetrix
Elite announces FDA approval of supplemental application for Hydromorphone
The Fly on the Wall
Thursday, January 26, 2012 - 11:25am
tags:
Elite Pharmaceuticals, FDA, hydromorphone hydrochloride

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.